![](https://d.newswise.com/assets/new/img/newswise-logo-square.jpg)
bioMerieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE(r) SPOTFIRE(r) Respiratory/Sore ...
Newswise — Marcy-l’Étoile (France), June 26th, 2024 – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. Food and Drug …